{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:26:53Z","timestamp":1787887613190,"version":"build-2784847793"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Influenza-associated encephalopathy (IAE) is a serious complication that can follow influenza virus infection. Once a cytokine storm is induced during influenza virus infection, tight junction protein disruption occurs, which consequently leads to blood-brain barrier (BBB) breakdown. However, the details of IAE pathogenesis are not well understood. Here, we established a murine IAE model by administration of lipopolysaccharide following influenza virus infection. Brains from IAE model mice had significantly higher expression of type I interferons and inflammatory cytokines. In addition, the expression of Caveolin<jats:italic>-<\/jats:italic>1, one of the key proteins that correlate with protection of the BBB, was significantly lower in brains from the IAE group compared with the control group. We also found that, among 84 different histone modification enzymes, only SET domain bifurcated 2 (Setdb2), one of the histone methyltransferases that methylates the lysine 9 of histone H3, showed significantly higher expression in the IAE group compared with the control group. Furthermore, chromatin immunoprecipitation revealed that methylation of histone H3 lysine 9 was correlated with repression of the <jats:italic>Caveolin-1<\/jats:italic> promoter region. These studies identify Caveolin-1 as a key regulator of BBB permeability in IAE and reveal that it acts through histone modification induced by Setdb2.<\/jats:p>","DOI":"10.1038\/s41598-018-36489-8","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T11:08:00Z","timestamp":1548155280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Abrogated Caveolin-1 expression via histone modification enzyme Setdb2 regulates brain edema in a mouse model of influenza-associated encephalopathy"],"prefix":"10.1038","volume":"9","author":[{"given":"Natsuko","family":"Imakita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kitabatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Ouji-Sageshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Morita-Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Wanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Mikasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"key":"36489_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1086\/341407","volume":"35","author":"T Morishima","year":"2002","unstructured":"Morishima, T. et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin. Infect. Dis. 35, 512\u2013517, https:\/\/doi.org\/10.1086\/341407 (2002).","journal-title":"Clin. Infect. Dis."},{"key":"36489_CR2","doi-asserted-by":"publisher","first-page":"e54786","DOI":"10.1371\/journal.pone.0054786","volume":"8","author":"Y Gu","year":"2013","unstructured":"Gu, Y. et al. National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009\u20132010 influenza pandemic. Plos One 8, e54786, https:\/\/doi.org\/10.1371\/journal.pone.0054786 (2013).","journal-title":"Plos One"},{"key":"36489_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/(SICI)1096-9071(199908)58:4<420::AID-JMV16>3.0.CO;2-T","volume":"58","author":"Y Ito","year":"1999","unstructured":"Ito, Y. et al. Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J. Med. Virol. 58, 420\u2013425 (1999).","journal-title":"J. Med. Virol."},{"key":"36489_CR4","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1542\/peds.2004-0143","volume":"114","author":"SM Maricich","year":"2004","unstructured":"Maricich, S. M. et al. Neurologic complications associated with influenza A in children during the 2003\u20132004 influenza season in Houston, Texas. Pediatrics 114, e626\u2013633, https:\/\/doi.org\/10.1542\/peds.2004-0143 (2004).","journal-title":"Pediatrics"},{"key":"36489_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.5692\/clinicalneurol.48.713","volume":"48","author":"H Yoshimura","year":"2008","unstructured":"Yoshimura, H. et al. Elderly autopsy case of influenza-associated encephalopathy. Rinsho Shinkeigaku 48, 713\u2013720 (2008).","journal-title":"Rinsho Shinkeigaku"},{"key":"36489_CR6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/jnen\/60.7.696","volume":"60","author":"S McCall","year":"2001","unstructured":"McCall, S., Henry, J. M., Reid, A. H. & Taubenberger, J. K. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases. J. Neuropathol. Exp. Neurol. 60, 696\u2013704 (2001).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"36489_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.5692\/clinicalneurol.52.480","volume":"52","author":"S Yamada","year":"2012","unstructured":"Yamada, S. et al. An autopsy case of pandemic (H1N1) 2009 influenza virus-associated encephalopathy. Rinsho Shinkeigaku 52, 480\u2013485 (2012).","journal-title":"Rinsho Shinkeigaku"},{"key":"36489_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1212\/WNL.57.2.295","volume":"57","author":"H Aiba","year":"2001","unstructured":"Aiba, H., Mochizuki, M., Kimura, M. & Hojo, H. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology 57, 295\u2013299 (2001).","journal-title":"Neurology"},{"key":"36489_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1212\/WNL.50.2.407","volume":"50","author":"T Ichiyama","year":"1998","unstructured":"Ichiyama, T., Nishikawa, M., Yoshitomi, T., Hayashi, T. & Furukawa, S. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures. Comparison with acute encephalitis\/encephalopathy. Neurology 50, 407\u2013411 (1998).","journal-title":"Neurology"},{"key":"36489_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/0036554021000026986","volume":"35","author":"T Ichiyama","year":"2003","unstructured":"Ichiyama, T. et al. Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy. Scand. J. Infect. Dis. 35, 59\u201361 (2003).","journal-title":"Scand. J. Infect. Dis."},{"key":"36489_CR11","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1442-200X.2003.01822.x","volume":"45","author":"T Ichiyama","year":"2003","unstructured":"Ichiyama, T. et al. Serum cytokine concentrations of influenza-associated acute necrotizing encephalopathy. Pediatr. Int. 45, 734\u2013736 (2003).","journal-title":"Pediatr. Int."},{"key":"36489_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cyto.2004.03.012","volume":"27","author":"T Ichiyama","year":"2004","unstructured":"Ichiyama, T. et al. Analysis of cytokine levels and NF-\u03baB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. Cytokine 27, 31\u201337, https:\/\/doi.org\/10.1016\/j.cyto.2004.03.012 (2004).","journal-title":"Cytokine"},{"key":"36489_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.virusres.2004.02.016","volume":"103","author":"T Togashi","year":"2004","unstructured":"Togashi, T., Matsuzono, Y., Narita, M. & Morishima, T. Influenza-associated acute encephalopathy in Japanese children in 1994\u20132002. Virus. Res. 103, 75\u201378, https:\/\/doi.org\/10.1016\/j.virusres.2004.02.016 (2004).","journal-title":"Virus. Res."},{"key":"36489_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1155\/2005\/671609","volume":"21","author":"M Nakamura","year":"2005","unstructured":"Nakamura, M. et al. Clinical application of rapid assay of interleukin-6 in influenza-associated encephalopathy. Dis. Markers 21, 199\u2013202 (2005).","journal-title":"Dis. Markers"},{"key":"36489_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cyto.2011.01.006","volume":"54","author":"S Hasegawa","year":"2011","unstructured":"Hasegawa, S. et al. Serum and cerebrospinal fluid cytokine profile of patients with 2009 pandemic H1N1 influenza virus-associated encephalopathy. Cytokine 54, 167\u2013172, https:\/\/doi.org\/10.1016\/j.cyto.2011.01.006 (2011).","journal-title":"Cytokine"},{"key":"36489_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1046\/j.1442-200x.2000.01204.x","volume":"42","author":"S Yokota","year":"2000","unstructured":"Yokota, S. et al. Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy. Pediatr. Int. 42, 197\u2013203 (2000).","journal-title":"Pediatr. Int."},{"key":"36489_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2165\/00003088-200746070-00002","volume":"46","author":"AG de Boer","year":"2007","unstructured":"de Boer, A. G. & Gaillard, P. J. Strategies to improve drug delivery across the blood-brain barrier. Clin. Pharmacokinet. 46, 553\u2013576, https:\/\/doi.org\/10.2165\/00003088-200746070-00002 (2007).","journal-title":"Clin. Pharmacokinet."},{"key":"36489_CR18","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1111\/febs.13412","volume":"282","author":"J Keaney","year":"2015","unstructured":"Keaney, J. & Campbell, M. The dynamic blood-brain barrier. FEBS J. 282, 4067\u20134079, https:\/\/doi.org\/10.1111\/febs.13412 (2015).","journal-title":"FEBS J."},{"key":"36489_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12035-013-8433-7","volume":"48","author":"F Dal-Pizzol","year":"2013","unstructured":"Dal-Pizzol, F. et al. Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood-brain barrier dysfunction in an animal model of severe sepsis. Mol. Neurobiol. 48, 62\u201370, https:\/\/doi.org\/10.1007\/s12035-013-8433-7 (2013).","journal-title":"Mol. Neurobiol."},{"key":"36489_CR20","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1038\/emboj.2009.271","volume":"28","author":"F De Santa","year":"2009","unstructured":"De Santa, F. et al. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J. 28, 3341\u20133352, https:\/\/doi.org\/10.1038\/emboj.2009.271 (2009).","journal-title":"EMBO J."},{"key":"36489_CR21","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/eji.200939739","volume":"40","author":"WF Carson","year":"2010","unstructured":"Carson, W. F. et al. Impaired CD4+ T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis. Eur. J. Immunol. 40, 998\u20131010, https:\/\/doi.org\/10.1002\/eji.200939739 (2010).","journal-title":"Eur. J. Immunol."},{"key":"36489_CR22","doi-asserted-by":"publisher","first-page":"e0121748","DOI":"10.1371\/journal.pone.0121748","volume":"10","author":"S Weiterer","year":"2015","unstructured":"Weiterer, S. et al. Sepsis induces specific changes in histone modification patterns in human monocytes. PLoS One 10, e0121748, https:\/\/doi.org\/10.1371\/journal.pone.0121748 (2015).","journal-title":"PLoS One"},{"key":"36489_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/bs.apcsb.2016.08.004","volume":"106","author":"WF Carson","year":"2017","unstructured":"Carson, W. F. & Kunkel, S. L. Regulation of cellular immune responses in sepsis by histone modifications. Adv. Protein. Chem. Struct. Biol. 106, 191\u2013225, https:\/\/doi.org\/10.1016\/bs.apcsb.2016.08.004 (2017).","journal-title":"Adv. Protein. Chem. Struct. Biol."},{"key":"36489_CR24","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.3892\/mmr.2016.5958","volume":"14","author":"L Jiang","year":"2016","unstructured":"Jiang, L., Wang, Y., Zhu, D., Xue, Z. & Mao, H. Alteration of histone H3 lysine 9 dimethylation in peripheral white blood cells of septic patients with trauma and cancer. Mol. Med. Rep. 14, 5467\u20135474, https:\/\/doi.org\/10.3892\/mmr.2016.5958 (2016).","journal-title":"Mol. Med. Rep."},{"key":"36489_CR25","doi-asserted-by":"publisher","unstructured":"Wei, J. et al. Regulation of the ubiquitylation and deubiquitylation of CREB-binding protein modulates histone acetylation and lung inflammation. Sci. Signal. 10, https:\/\/doi.org\/10.1126\/scisignal.aak9660 (2017).","DOI":"10.1126\/scisignal.aak9660"},{"key":"36489_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-5728(95)00064-9","volume":"60","author":"M Hayashi","year":"1995","unstructured":"Hayashi, M., Luo, Y., Laning, J., Strieter, R. M. & Dorf, M. E. Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells. J. Neuroimmunol. 60, 143\u2013150 (1995).","journal-title":"J. Neuroimmunol."},{"key":"36489_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jns.2012.04.013","volume":"318","author":"GH Kang","year":"2012","unstructured":"Kang, G. H. et al. Neuroprotective effect of fucoidin on lipopolysaccharide accelerated cerebral ischemic injury through inhibition of cytokine expression and neutrophil infiltration. J. Neurol. Sci. 318, 25\u201330, https:\/\/doi.org\/10.1016\/j.jns.2012.04.013 (2012).","journal-title":"J. Neurol. Sci."},{"key":"36489_CR28","first-page":"530","volume":"9","author":"TK Varma","year":"2002","unstructured":"Varma, T. K., Lin, C. Y., Toliver-Kinsky, T. E. & Sherwood, E. R. Endotoxin-induced gamma interferon production: contributing cell types and key regulatory factors. Clin Diagn Lab Immunol 9, 530\u2013543 (2002).","journal-title":"Clin Diagn Lab Immunol"},{"key":"36489_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/13550281003682521","volume":"16","author":"T Tanaka","year":"2010","unstructured":"Tanaka, T. et al. Lipopolysaccharide treatment and inoculation of influenza A virus results in influenza virus-associated encephalopathy-like changes in neonatal mice. J. Neurovirol. 16, 125\u2013132, https:\/\/doi.org\/10.3109\/13550281003682521 (2010).","journal-title":"J. Neurovirol."},{"key":"36489_CR30","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/jmv.23801","volume":"86","author":"Y Kyan","year":"2014","unstructured":"Kyan, Y. et al. Transcriptome profiling of brain edemas caused by influenza infection and lipopolysaccharide treatment. J. Med. Virol. 86, 905\u2013911, https:\/\/doi.org\/10.1002\/jmv.23801 (2014).","journal-title":"J. Med. Virol."},{"key":"36489_CR31","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jmv.25076","volume":"90","author":"N Nosaka","year":"2018","unstructured":"Nosaka, N. et al. Anti-high mobility group box-1 monoclonal antibody treatment of brain edema induced by influenza infection and lipopolysaccharide. J. Med. Virol. 90, 1192\u20131198, https:\/\/doi.org\/10.1002\/jmv.25076 (2018).","journal-title":"J. Med. Virol."},{"key":"36489_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/jhg.2013.66","volume":"58","author":"H Kimura","year":"2013","unstructured":"Kimura, H. Histone modifications for human epigenome analysis. J. Hum. Genet. 58, 439\u2013445, https:\/\/doi.org\/10.1038\/jhg.2013.66 (2013).","journal-title":"J. Hum. Genet."},{"key":"36489_CR33","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1113\/jphysiol.2007.146852","volume":"586","author":"C F\u00f6rster","year":"2008","unstructured":"F\u00f6rster, C. et al. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J. Physiol. 586, 1937\u20131949, https:\/\/doi.org\/10.1113\/jphysiol.2007.146852 (2008).","journal-title":"J. Physiol."},{"key":"36489_CR34","doi-asserted-by":"publisher","first-page":"e110024","DOI":"10.1371\/journal.pone.0110024","volume":"9","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Interleukin-1\u03b2 induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes. PLoS One 9, e110024, https:\/\/doi.org\/10.1371\/journal.pone.0110024 (2014).","journal-title":"PLoS One"},{"key":"36489_CR35","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1091\/mbc.e05-03-0193","volume":"16","author":"M Utech","year":"2005","unstructured":"Utech, M. et al. Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 16, 5040\u20135052, https:\/\/doi.org\/10.1091\/mbc.e05-03-0193 (2005).","journal-title":"Mol Biol Cell"},{"key":"36489_CR36","doi-asserted-by":"publisher","first-page":"e1005096","DOI":"10.1371\/journal.ppat.1005096","volume":"11","author":"BP Daniels","year":"2015","unstructured":"Daniels, B. P. & Klein, R. S. Knocking on closed doors: Host interferons dynamically regulate blood-brain barrier function during viral infections of the central nervous system. PLoS Pathog 11, e1005096, https:\/\/doi.org\/10.1371\/journal.ppat.1005096 (2015).","journal-title":"PLoS Pathog"},{"key":"36489_CR37","doi-asserted-by":"publisher","first-page":"2594231","DOI":"10.1155\/2017\/2594231","volume":"2017","author":"Y Nagaoka","year":"2017","unstructured":"Nagaoka, Y. et al. Local and systemic immune responses to influenza A virus infection in pneumonia and encephalitis mouse models. Dis. Markers 2017, 2594231, https:\/\/doi.org\/10.1155\/2017\/2594231 (2017).","journal-title":"Dis. Markers"},{"key":"36489_CR38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/jmv.10088","volume":"67","author":"M Shinjoh","year":"2002","unstructured":"Shinjoh, M. et al. Prophylaxis and treatment of influenza encephalitis in an experimental mouse model. J. Med. Virol. 67, 406\u2013417, https:\/\/doi.org\/10.1002\/jmv.10088 (2002).","journal-title":"J. Med. Virol."},{"key":"36489_CR39","doi-asserted-by":"crossref","unstructured":"G\u00e4rdenfors, A., Nilsson, F., Skagerberg, G., Ungerstedt, U. & Nordstr\u00f6m, C. H. Cerebral physiological and biochemical changes during vasogenic brain edema induced by intrathecal injection of bacterial lipopolysaccharides in piglets. Acta. Neurochir. (Wien) 144, 601\u2013608; discussion 608\u2013609 (2002).","DOI":"10.1007\/s00701-002-0954-1"},{"key":"36489_CR40","doi-asserted-by":"publisher","first-page":"e1005338","DOI":"10.1371\/journal.ppat.1005338","volume":"11","author":"DN Kroetz","year":"2015","unstructured":"Kroetz, D. N. et al. Type I interferon induced epigenetic regulation of macrophages suppresses innate and adaptive immunity in acute respiratory viral infection. PLoS Pathog. 11, e1005338, https:\/\/doi.org\/10.1371\/journal.ppat.1005338 (2015).","journal-title":"PLoS Pathog."},{"key":"36489_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ni.3046","volume":"16","author":"C Schliehe","year":"2015","unstructured":"Schliehe, C. et al. The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. Nat. Immunol. 16, 67\u201374, https:\/\/doi.org\/10.1038\/ni.3046 (2015).","journal-title":"Nat. Immunol."},{"key":"36489_CR42","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1101\/gad.989402","volume":"16","author":"M Tachibana","year":"2002","unstructured":"Tachibana, M. et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16, 1779\u20131791, https:\/\/doi.org\/10.1101\/gad.989402 (2002).","journal-title":"Genes Dev."},{"key":"36489_CR43","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1101\/gad.973302","volume":"16","author":"DC Schultz","year":"2002","unstructured":"Schultz, D. C., Ayyanathan, K., Negorev, D., Maul, G. G. & Rauscher, F. J. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 16, 919\u2013932, https:\/\/doi.org\/10.1101\/gad.973302 (2002).","journal-title":"Genes Dev."},{"key":"36489_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1139\/o03-071","volume":"82","author":"AF Quest","year":"2004","unstructured":"Quest, A. F., Leyton, L. & P\u00e1rraga, M. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem. Cell Biol. 82, 129\u2013144, https:\/\/doi.org\/10.1139\/o03-071 (2004).","journal-title":"Biochem. Cell Biol."},{"key":"36489_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0306-4522(02)00374-3","volume":"115","author":"D Virgintino","year":"2002","unstructured":"Virgintino, D. et al. Expression of caveolin-1 in human brain microvessels. Neuroscience 115, 145\u2013152 (2002).","journal-title":"Neuroscience"},{"key":"36489_CR46","doi-asserted-by":"publisher","first-page":"40091","DOI":"10.1074\/jbc.M205948200","volume":"277","author":"W Schubert","year":"2002","unstructured":"Schubert, W. et al. Microvascular hyperpermeability in caveolin-1 (\u2212\/\u2212) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. J. Biol. Chem. 277, 40091\u201340098, https:\/\/doi.org\/10.1074\/jbc.M205948200 (2002).","journal-title":"J. Biol. Chem."},{"key":"36489_CR47","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1182\/blood-2006-07-034009","volume":"109","author":"L Song","year":"2007","unstructured":"Song, L., Ge, S. & Pachter, J. S. Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood 109, 1515\u20131523, https:\/\/doi.org\/10.1182\/blood-2006-07-034009 (2007).","journal-title":"Blood"},{"key":"36489_CR48","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1471-4159.2011.07542.x","volume":"120","author":"Y Gu","year":"2012","unstructured":"Gu, Y. et al. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J. Neurochem. 120, 147\u2013156, https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07542.x (2012).","journal-title":"J. Neurochem."},{"key":"36489_CR49","doi-asserted-by":"publisher","first-page":"67857","DOI":"10.18632\/oncotarget.12346","volume":"7","author":"KH Choi","year":"2016","unstructured":"Choi, K. H. et al. Overexpression of caveolin-1 attenuates brain edema by inhibiting tight junction degradation. Oncotarget 7, 67857\u201367867, https:\/\/doi.org\/10.18632\/oncotarget.12346 (2016).","journal-title":"Oncotarget"},{"key":"36489_CR50","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1165\/rcmb.2005-0376OC","volume":"34","author":"XM Wang","year":"2006","unstructured":"Wang, X. M., Kim, H. P., Song, R. & Choi, A. M. Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3\/p38 MAPK pathway. Am. J. Respir. Cell Mol. Biol. 34, 434\u2013442, https:\/\/doi.org\/10.1165\/rcmb.2005-0376OC (2006).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"36489_CR51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1348-0421.2010.00226.x","volume":"54","author":"M Tsuge","year":"2010","unstructured":"Tsuge, M. et al. Increase of tumor necrosis factor-alpha in the blood induces early activation of matrix metalloproteinase-9 in the brain. Microbiol. Immunol. 54, 417\u2013424, https:\/\/doi.org\/10.1111\/j.1348-0421.2010.00226.x (2010).","journal-title":"Microbiol. Immunol."},{"key":"36489_CR52","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.2741\/222","volume":"3","author":"Y Gu","year":"2011","unstructured":"Gu, Y., Dee, C. M. & Shen, J. Interaction of free radicals, matrix metalloproteinases and caveolin-1 impacts blood-brain barrier permeability. Front. Biosci. (Schol Ed) 3, 1216\u20131231 (2011).","journal-title":"Front. Biosci. (Schol Ed)"},{"key":"36489_CR53","doi-asserted-by":"publisher","first-page":"e530","DOI":"10.1097\/CCM.0000000000001562","volume":"44","author":"T Ito","year":"2016","unstructured":"Ito, T. et al. Sprouty-Related Ena\/Vasodilator-stimulated phosphoprotein homology 1-domain-containing protein-2 critically regulates influenza A virus-induced pneumonia. Crit. Care. Med. 44, e530\u2013543, https:\/\/doi.org\/10.1097\/CCM.0000000000001562 (2016).","journal-title":"Crit. Care. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36489-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36489-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36489-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:45:19Z","timestamp":1671252319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36489-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["36489"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-36489-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,22]]},"assertion":[{"value":"31 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"284"}}